arm 1 + LUSEDRA + Propofol (arm 3)
Phase 1Completed 0 watching 0 views this week💤 Quiet
33
Development Stage
✓
Pre-clinical2
Phase 13
Phase 24
Phase 35
ApprovedIndication / Disease
Monitored Anesthesia Care
Conditions
Monitored Anesthesia Care
Trial Timeline
Jan 1, 2011 → Aug 1, 2011
NCT ID
NCT01308541About arm 1 + LUSEDRA + Propofol (arm 3)
arm 1 + LUSEDRA + Propofol (arm 3) is a phase 1 stage product being developed by Eisai for Monitored Anesthesia Care. The current trial status is completed. This product is registered under clinical trial identifier NCT01308541. Target conditions include Monitored Anesthesia Care.
Hype Score Breakdown
Clinical
10
Activity
5
Company
10
Novelty
3
Community
2
Clinical Trials (1)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01308541 | Phase 1 | Completed |